Literature DB >> 15943652

Self-administered instrument to measure the patient's experience of recovery after first-episode psychosis: development and validation of the Psychosis Recovery Inventory.

Eric Y H Chen1, Dennise K P Tam, Josephine W S Wong, C W Law, Cindy P Y Chiu.   

Abstract

OBJECTIVE: Patients who are recovering from a first-episode psychosis face specific and complex issues that are related to their illness and treatment experiences, such as the appraisal of the extent of their recovery and the risk of relapse. Currently, no instrument provides a comprehensive assessment of these related attitudes. A novel self-administered rating scale for the measurement of key perceptions during the recovery stage after a first-episode psychosis is presented. The Psychosis Recovery Inventory (PRI) is designed to specifically address a number of closely related issues that are faced by patients who are recovering from a first-episode psychosis.
METHOD: The process of development of the PRI involved the generation of items from qualitative interviews, the construction and refinement of these items and a validation study. The longitudinal stability of the PRI items was assessed in a test-retest reliability study in which 20 patients completed the retest within 4 weeks. The internal consistency and convergent validity of the PRI were evaluated by a comparison of the PRI subscale scores and the Scale to Assess Unawareness of Mental Disorder and Drug Attitude Inventory scores in a sample of 48 first-episode psychosis patients.
RESULTS: The validation study shows that the PRI is an instrument with a good test-retest reliability, internal consistency and convergent validity.
CONCLUSIONS: This pragmatic, low burden, self-administered scale can be applied in clinical and research settings to obtain reliable information on the attitudes of patients on a range of interrelated issues in the recovery stage that follows a first-episode psychosis.

Entities:  

Mesh:

Year:  2005        PMID: 15943652     DOI: 10.1080/j.1440-1614.2005.01609.x

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  7 in total

1.  Psychiatric symptoms and HPA axis function in adolescent methamphetamine users.

Authors:  George King; Daniel Alicata; Christine Cloak; Linda Chang
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-01       Impact factor: 4.147

2.  The Eating Disorders Recovery Questionnaire: psychometric properties and validity.

Authors:  Rachel Bachner-Melman; Lilac Lev-Ari; Ada H Zohar; Michal Linketsky
Journal:  Eat Weight Disord       Date:  2021-02-13       Impact factor: 4.652

3.  Perceived risk of relapse and role of medication: comparison between patients with psychosis and their caregivers.

Authors:  Kit Wa Sherry Chan; Men Heng Marian Wong; Christy Lai Ming Hui; Edwin Ho Ming Lee; Wing Chung Chang; Eric Yu Hai Chen
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-07-24       Impact factor: 4.328

4.  Adolescent attitudes toward psychiatric medication: the utility of the Drug Attitude Inventory.

Authors:  Lisa Townsend; Jerry Floersch; Robert L Findling
Journal:  J Child Psychol Psychiatry       Date:  2009-07-21       Impact factor: 8.982

Review 5.  Systematic review reveals heterogeneity in the use of the Scale to Assess Unawareness of Mental Disorder (SUMD).

Authors:  Rémy Dumas; Karine Baumstarck; Pierre Michel; Christophe Lançon; Pascal Auquier; Laurent Boyer
Journal:  Curr Psychiatry Rep       Date:  2013-06       Impact factor: 5.285

6.  Recovery in psychosis: a Delphi study with experts by experience.

Authors:  Heather Law; Anthony P Morrison
Journal:  Schizophr Bull       Date:  2014-04-12       Impact factor: 9.306

7.  Predictive validity of the Sidorkiewicz instrument in Spanish: Assessing individual drug adherence in psychiatric patients.

Authors:  Carlos De Las Cuevas; Wenceslao Peñate; José Manuel García de Cecilia; Jose de Leon
Journal:  Int J Clin Health Psychol       Date:  2017-12-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.